Advice
Following a full submission
Duloxetine (Cymbalta) is accepted for restricted use within NHS Scotland for the treatment of major depressive episodes in accordance with existing guidelines (i.e. in patients who have not responded to or are unable to tolerate initial treatment options).
On the basis of the limited comparative data available, duloxetine appears to offer similar efficacy to other antidepressants in this treatment position at a similar cost.
Download detailed advice51KB (PDF)
Medicine details
- Medicine name:
- Duloxetine 30mg, 60mg capsules (Cymbalta®)
- SMC ID:
- 195/05
- Indication:
- Major depressive episodes
- Pharmaceutical company
- Eli Lilly and Company Ltd
- BNF chapter
- Central nervous system
- Submission type
- Full
- Status
- Restricted
- Date advice published
- 12 September 2005